Cargando…

Synthetic peptide antigen corresponding to the major sites of T-lymphocyte recognition within the HIV virus envelope protein: recombinant vaccine production

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 1989
Materias:	Patent Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131213/ http://dx.doi.org/10.1016/0264-410X(89)90221-1

Ejemplares similares

Nucleic acid constructs, malaria polypeptides and vaccines; recombinant malaria serine-repeat antigen production in yeast for the construction of a recombinant vaccine
Publicado: (1992)

Envelope region nucleic acid fragment of type-C hepatitis virus and its detection; diagnosis using hepatitic C virus DNA probe or RNA probe; DNA sequence; potential recombinant vaccine preparation
Publicado: (1993)

Heterologous virus peptide immunogen production: recombinant vaccine production in L-cell, Chinese hamster ovary, C127 cell culture
Publicado: (1989)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Expired Patents
Publicado: (1907)

Patents of Interest to Dentists Recently Granted
Publicado: (1907)

Expired Patents
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

New dengue virus Type-1 strain; recombinant DEN1 protein expression; potential in recombinant vaccine construction, virus detection and dengue fever diagnosis and therapy
Publicado: (1994)

Non-infective structural particle preparation containing flavivirus surface antigen protein; Japanese-encephalitis virus cDNA gene cloning in dengue virus-2-preinfected cell with a vaccinia virus vector and use of a non-infective structural particle as recombinant vaccine
Publicado: (1994)

Universal coronavirus vaccine; spike protein cloning and expression for use as a recombinant vaccine
Publicado: (1994)

New epitope-bearing portions of Entamoeba histolytica; recombinant non-glycosylated epitope production and expression in prokaryote host cell, for application in a recombinant vaccine : Univ. Virginia Pat. Found. World 9500 849; 5 January 1995
Publicado: (1995)

Nematode protein complex; Haemonchus contortus immunogen and anthelmintic agent; protein sequence; recombinant vaccine production
Publicado: (1991)

5417986 Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres : Reid Robert H; Boedeker Edgar; van Hamont John; Setterstrom Jean A Kensington, MD, United States Assigned to The United States of America as represented by the Secretary of the Army
Publicado: (1996)

Vaccine against Schistosoma mansoni containing soluble antigen from larvae or adults
Publicado: (1986)

Antigen specific to non-A, non-B hepatitis virus: application for vaccine production
Publicado: (1987)

Antigens of Cysticercus cellulosae; used for antibody production, treatment of neurocysticercosis, diagnosis or vaccine production
Publicado: (1991)

Ringworm vaccine; containing antigen from e.g. Microsporum canis, Microsporum gypsum or Trichophyton mentagrophytes
Publicado: (1991)

Plasmodium Duffy receptor protein; Plasmodium knowlesi or Plasmodium vivax gene cloning and expression; potential recombinant vaccine against malaria; DNA sequence
Publicado: (1992)

Transgenic plant expressing antigen of pathogenic organism; e.g. using Escherichia coli or Streptococcus mutans, used for oral immunization to inhibit colonization or invasion by pathogens
Publicado: (1991)

Recombinant Pseudomonas exotoxin produced by cloning of Pseudomonas aeruginosa DNA in Escherichia coli having low toxicity to human or mice cells but retaining enzymatic activity giving cell-specific immunotoxin; vaccine application
Publicado: (1988)

cDNA clone of non-A non-B hepatitis virus (NANB) post transfusion and its use — DNA sequence; potential application as recombinant vaccine; DNA probe application in disease diagnosis
Publicado: (1991)

Preparation of a helicase region coded by hepatitis C virus; hepatitis C virus recombinant helicase production via gene cloning and expression in Spodoptera frugiperda insect cell culture using baculovirus vector : Soyaku Eng. Res. Inst. Jpn 06319 583; 22 November 1994
Publicado: (1995)

Gene encoding H-protein of sclerosing-panencephalitis virus, a potential vaccine
Publicado: (1989)

4824785 Canine corona virus vaccine: William M Acree, Bobby Edwards, John W Black assigned to American Home Products Corp (Del)
Publicado: (1989)

Bordetella pertussis coding sequences used for producing polypeptides that retain immunogenicity but lack virulence for vaccine production
Publicado: (1989)

A Novelty System for Biotization of Plant Microshoots and Collection of Natural Compounds
por: Castro, Mário Rui da Costa Basílio e, et al.
Publicado: (2019)

Patent survey on biotechnology advances
por: Terpstra, Marten
Publicado: (2005)

5580786 Dual Chamber blood culture bottle with syringe capture and piston assembly : Gombrich Peter; Domanik Richard A; Mayer William Chicago, IL, United States Assigned to AccuMed Inc
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_sjgkfug48t6rumhpcf6vko7sgo